Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Optimal duration of fluorouracil-based adjuvant chemotherapy for patients with resectable gastric cancer.

Qu JL, Li X, Qu XJ, Zhu ZT, Zhou LZ, Teng YE, Zhang JD, Jin B, Zhao MF, Yu P, Liu YP.

PLoS One. 2013 Dec 26;8(12):e83196. doi: 10.1371/journal.pone.0083196. eCollection 2013.

2.

Early initiation of fluorouracil-based adjuvant chemotherapy improves survival in patients with resectable gastric cancer.

Qu JL, Qu XJ, Li X, Zhang JD, Teng YE, Jin B, Zhao MF, Yu P, Liu J, Li DY, Liu YP.

J BUON. 2015 May-Jun;20(3):800-7.

PMID:
26214633
3.

Retrospective analysis of adjuvant chemotherapy for curatively resected gastric cancer.

Deng W, Wang QW, Zhang XT, Lu M, Li J, Li Y, Gong JF, Zhou J, Lu ZH, Shen L.

World J Gastroenterol. 2014 Mar 28;20(12):3356-63. doi: 10.3748/wjg.v20.i12.3356.

4.

Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.

Jin J, Liao Z, Zhang Z, Ajani J, Swisher S, Chang JY, Jeter M, Guerrero T, Stevens CW, Vaporciyan A, Putnam J Jr, Walsh G, Smythe R, Roth J, Yao J, Allen P, Cox JD, Komaki R.

Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):427-36.

PMID:
15380576
5.

Impact of adjuvant chemotherapy cycles on prognosis of resectable stomach cancer: a retrospective analysis.

Zhang WY, Zhang WJ, Bai Y, Yuan HH, Liu F, Gao J, Gong YF, Jiang B.

Asian Pac J Cancer Prev. 2013;14(1):381-6.

6.

Adjuvant chemotherapy with 5-fluorouracil, doxorubicin and mitomycin-C (FAM) for 6 months after curative resection of gastric carcinoma.

Koo DH, Lee JL, Kim TW, Chang HM, Ryu MH, Yook JH, Oh ST, Kim BS, Lee JS, Kang YK.

Eur J Surg Oncol. 2007 Sep;33(7):843-8. Epub 2007 Jan 5.

PMID:
17207959
7.

5-fluorouracil, mitomycin-C, and polysaccharide-K adjuvant chemoimmunotherapy for locally advanced gastric cancer: the prognostic significance of frequent perineural invasion.

Choi JH, Kim YB, Lim HY, Park JS, Kim HC, Cho YK, Han SW, Kim MW, Joo HJ.

Hepatogastroenterology. 2007 Jan-Feb;54(73):290-7.

PMID:
17419278
8.

Outcomes of adjuvant chemoradiotherapy after a radical gastrectomy and a D2 node dissection for gastric adenocarcinoma.

Leong CN, Chung HT, Lee KM, Shakespeare TP, Mukherjee RK, Wong LC, Lu JJ, Tey J, Lim R, So JB, Back MF.

Cancer J. 2008 Jul-Aug;14(4):269-75. doi: 10.1097/PPO.0b013e318178d23a.

PMID:
18677137
9.

Adjuvant 5-fluorouracil plus doxorubicin in D2-3 resected gastric carcinoma: 15-year experience at a single institute.

Jeung HC, Rha SY, Noh SH, Min JS, Kim BS, Chung HC.

Cancer. 2001 Jun 1;91(11):2016-25.

PMID:
11391580
10.

Folinic acid, 5-fluorouracil and etoposide after curative resection for gastric cancer.

Petrioli R, Sabatino M, Roviello F, Marrelli D, Nastri G, Marsili S, Correale P, Pozzessere D, Messinese S, De Martino A, Tani F, Marzocca G, Lorenzi M, Civitelli S, Tanzini G, Pinto E, Francini G.

Hepatogastroenterology. 2005 Sep-Oct;52(65):1626-30.

PMID:
16201130
11.

[Impact of AJCC staging system (2010 edition) on the choice of postoperative adjuvant chemotherapy after radical resection of gastric cancer].

Yu YY, Liu TS, Wang ZM, Li W.

Zhonghua Wei Chang Wai Ke Za Zhi. 2012 Jun;15(6):599-602. Chinese.

PMID:
22736131
12.

[Early postoperative intraperitoneal chemotherapy for the treatment of advanced gastric cancer].

Markelis R, Endzinas Z, Grižas S, Pundzius J, Saladžinskas Z, Juozaitytė E, Inčiūra A, Pranys D, Maleckas A.

Medicina (Kaunas). 2011;47(1):63-9. Lithuanian.

14.

A phase II trial of Xeloda and oxaliplatin (XELOX) neo-adjuvant chemotherapy followed by surgery for advanced gastric cancer patients with para-aortic lymph node metastasis.

Wang Y, Yu YY, Li W, Feng Y, Hou J, Ji Y, Sun YH, Shen KT, Shen ZB, Qin XY, Liu TS.

Cancer Chemother Pharmacol. 2014 Jun;73(6):1155-61. doi: 10.1007/s00280-014-2449-1. Epub 2014 Apr 21.

15.

Expression of multidrug resistance-associated proteins and their relation to postoperative individualized chemotherapy in gastric cancer.

Yu P, Du Y, Cheng X, Yu Q, Huang L, Dong R.

World J Surg Oncol. 2014 Oct 11;12:307. doi: 10.1186/1477-7819-12-307.

16.

Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC.

Di Costanzo F, Gasperoni S, Manzione L, Bisagni G, Labianca R, Bravi S, Cortesi E, Carlini P, Bracci R, Tomao S, Messerini L, Arcangeli A, Torri V, Bilancia D, Floriani I, Tonato M; Italian Oncology Group for Cancer Research, Dinota A, Strafiuso G, Corgna E, Porrozzi S, Boni C, Rondini E, Giunta A, Monzio Compagnoni B, Biagioni F, Cesari M, Fornarini G, Nelli F, Carboni M, Cognetti F, Enzo MR, Piga A, Romiti A, Olivetti A, Masoni L, De Stefanis M, Dalla Mola A, Camera S, Recchia F, De Filippis S, Scipioni L, Zironi S, Luppi G, Italia M, Banducci S, Pisani Leretti A, Massidda B, Ionta MT, Nicolosi A, Canaletti R, Biscottini B, Grigniani F, Di Costanzo F, Rovei R, Croce E, Carroccio R, Gilli G, Cavalli C, Olgiati A, Pandolfi U, Rossetti R, Natalini G, Foa P, Oldani S, Bruno L, Cascinu S, Catalano G, Catalano V, Lungarotti F, Farris A, Sarobba MG, Trignano M, Muscogiuri A, Francavilla F, Figoli F, Leoni M, Papiani G, Orselli G, Antimi M, Bellini V, Cabassi A, Contu A, Pazzola A, Frignano M, Lastraioli E, Saggese M, Bianchini D, Antonuzzo L, Mela M, Camisa R.

J Natl Cancer Inst. 2008 Mar 19;100(6):388-98. doi: 10.1093/jnci/djn054. Epub 2008 Mar 11.

PMID:
18334706
17.

A systematic overview of chemotherapy effects in colorectal cancer.

Ragnhammar P, Hafström L, Nygren P, Glimelius B; SBU-group. Swedish Council of Technology Assessment in Health Care.

Acta Oncol. 2001;40(2-3):282-308. Review.

PMID:
11441937
18.

Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1.

Nashimoto A, Nakajima T, Furukawa H, Kitamura M, Kinoshita T, Yamamura Y, Sasako M, Kunii Y, Motohashi H, Yamamoto S; Gastric Cancer Surgical Study Group, Japan Clinical Oncology Group.

J Clin Oncol. 2003 Jun 15;21(12):2282-7.

PMID:
12805327
19.

Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trial.

de Gramont A, Van Cutsem E, Schmoll HJ, Tabernero J, Clarke S, Moore MJ, Cunningham D, Cartwright TH, Hecht JR, Rivera F, Im SA, Bodoky G, Salazar R, Maindrault-Goebel F, Shacham-Shmueli E, Bajetta E, Makrutzki M, Shang A, André T, Hoff PM.

Lancet Oncol. 2012 Dec;13(12):1225-33. doi: 10.1016/S1470-2045(12)70509-0. Epub 2012 Nov 16.

PMID:
23168362
20.

Prolonged adjuvant capecitabine chemotherapy improved survival of stage IIIA gastric cancer after D2 gastrectomy.

Feng WM, Tang CW, Guo HH, Bao Y, Fei MY.

Biomed Pharmacother. 2015 May;72:140-3. doi: 10.1016/j.biopha.2015.03.003. Epub 2015 Apr 2.

PMID:
26054688

Supplemental Content

Support Center